0001140361-21-021489.txt : 20210617
0001140361-21-021489.hdr.sgml : 20210617
20210617184533
ACCESSION NUMBER: 0001140361-21-021489
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210615
FILED AS OF DATE: 20210617
DATE AS OF CHANGE: 20210617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Freitag Gregory Gene
CENTRAL INDEX KEY: 0001492710
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 211026379
MAIL ADDRESS:
STREET 1: 13631 PROGRESS BLVD.
CITY: ALACHUA
STATE: FL
ZIP: 32615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDS Biotechnology Corp
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 25B VREELAND ROAD
STREET 2: SUITE 300
CITY: FLORHAM PARK
STATE: NJ
ZIP: 07932
FORMER COMPANY:
FORMER CONFORMED NAME: Edge Therapeutics, Inc.
DATE OF NAME CHANGE: 20090911
4
1
form4.xml
FORM 4
X0306
4
2021-06-15
0001472091
PDS Biotechnology Corp
PDSB
0001492710
Freitag Gregory Gene
C/O PDS BIOTECHNOLOGY CORPORATION
25B VREELAND ROAD
FLORHAM PARK
NJ
07932
true
Common Stock
2021-06-15
4
P
0
5882
8.5
A
46153
D
Stock Option (Right to Buy)
9.95
2021-06-17
4
A
0
9000
0
A
2031-06-17
Common Stock
9000
9000
D
Represents shares of common stock purchased by the Reporting Person at the public offering price in connection with the Issuer's firm commitment underwritten public offering of common stock, which closed on June 17, 2021, and such shares of common stock are subject to a lock up agreement between the Reporting Person and Cantor Fitzgerald & Co., pursuant to which the shares cannot be sold for 90 days following June 15, 2021.
The Stock Option will vest in full and become fully exercisable on June 17, 2022.
/s/ Hillary Yegen, attorney-in-fact
2021-06-17